AADI - Aadi Bioscience appoints Dave Lennon Ph.D. as chief executive officer
2023-10-02 08:16:39 ET
- Aadi Bioscience ( NASDAQ: AADI ) appoints Dave Lennon, Ph.D. as President, board member and Chief Executive Officer.
- In connection with Dr. Lennon's appointment, Scott Giacobello, who served as Interim Chief Executive Officer and President since March 2023, will continue in his role as Chief Financial Officer.
- On track for interim analysis on 40 patients in tumor agnostic PRECISION1 trial in patients with TSC1/TSC2 alterations and trial initiations in endometrial and neuroendocrine cancers before the end of 2023
- Source: Press Release
For further details see:
Aadi Bioscience appoints Dave Lennon Ph.D. as chief executive officer